Abstract
Rodents have extensively used in the production of ischemic stroke. However, effective therapeutical treatments have been tested in the rodent stroke model and have often been ineffective when tested clinically. Subsequently, to close the gap between human and rodent studies, the panel of the Academic Stroke Therapy Committee (STAIR) recommends using non-human primates (NHP) for translational stroke and pre-clinical research. NHP is similar to the human brain through brain metabolism, white/gray matter ratio, cerebrovascular system, and abundant behavioral capabilities. Most ischemic strokes are ephemeral and permanent middle cerebral artery (MCA) occlusion foremost to stroke due to an embolic or filamentous method. This chapter will provide a summary of the transient and permanent occlusion of the MCA in the NHP. The advantage, disadvantages, and potential applications shall be examined for each model. The NHP model of transient focal cerebral ischemia offers excellent opportunities to understand the cellular and vascular pathophysiology of ischemic brain injury that mimics human stroke and the suitable model for pharmacological interventions in relevant human contexts.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- NHP:
-
Non human primate
- MCA:
-
Middle cerebral artery occlusion
- rtPA:
-
Recombinant tissue plasminogen artery
- STAIR:
-
Stroke therapy academic industry roundtable
- MCAO:
-
Middle cerebral artery occlusion
- RCBF:
-
Regional cerebral blood flow
References
Borlongan CV, Jolkkonen J, Detante O (2015) The future of stem cell therapy for stroke rehabilitation. Future Neurol 10(4):313–319
Bruns CM, Baum ST, Colman RJ, Eisner JR, Kemnitz JW, Weindruch R, Abbott DH (2004) Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys. J Clin Endocrinol Metabol 89(12):6218–6223
Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R (2009) Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325(5937):201–204
Cook DJ, Tymianski M (2012) Nonhuman primate models of stroke for translational neuroprotection research. Neurotherapeutics 9(2):371–379
Cook DJ, Teves L, Tymianski M (2012a) Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature 483(7388):213–217
Cook DJ, Teves L, Tymianski M (2012b) A translational paradigm for the pre-clinical evaluation of the stroke neuroprotectant Tat-NR2B9c in gyrencephalic non-human primates. Sci Transl Med 4(154):154ra133
D'Arceuil HE, Duggan M, He J, Pryor J, de Crespigny A (2006) Middle cerebral artery occlusion in Macaca fascicularis: acute and chronic stroke evolution. J Med Primatol 35(2):78–86
de Crespigny AJ, D’Arceuil HE, Maynard KI, He J, McAuliffe D, Norbash A, Sehgal PK, Hamberg L, Hunter G, Budzik RF, Putman CM (2005) Acute studies of a new primate model of reversible middle cerebral artery occlusion. J Stroke Cerebrovasc Dis 14(2):80–87
Del Zoppo GJ, Copeland BR, Harker LA, Waltz TA, Zyroff JA, Hanson SR, Battenberg EL (1986) Experimental acute thrombotic stroke in baboons. Stroke 17(6):1254–1265
Fisher M, Saver JL (2015) Future directions of acute ischaemic stroke therapy. Lancet Neurol 14(7):758–767
Gao H, Liu Y, Lu S, Xiang B, Wang C (2006) A reversible middle cerebral artery occlusion model using intraluminal balloon technique in monkeys. J Stroke Cerebrovasc Dis 15(5):202–208
Gauberti M, Obiang P, Guedin P, Balossier A, Gakuba C, Diependaele AS, Chazalviel L, Vivien D, Young AR, Agin V, Orset C (2012) Thrombotic stroke in the anesthetized monkey (Macaca mulatta): characterization by MRI–a pilot study. Cerebrovasc Dis 33(4):329–339
Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Dávalos A, Majoie CB, van der Lugt A, De Miquel MA, Donnan GA (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387(10029):1723–1731
Grow DA, McCarrey JR, Navara CS (2016) Advantages of non-human primates as pre-clinical models for evaluating stem cell-based therapies for Parkinson’s disease. Stem Cell Res 17(2):352–366
Guo J, Zheng HB, Duan JC, He L, Chen N, Gong QY, Tang HH, Li HX, Wang L, Cheng JQ (2011) Diffusion tensor MRI for the assessment of cerebral ischemia/reperfusion injury in the penumbra of non-human primate stroke model. Neurol Res 33(1):108–112
Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R (1996) ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 53(4):309–315
Hamberg LM, Hunter GJ, Maynard KI, Owen C, Morris PP, Putman CM, Ogilvy C, González RG, Functional CT (2002) Perfusion imaging in predicting the extent of cerebral infarction from a 3-hour middle cerebral arterial occlusion in a primate stroke model. Am J Neuroradiol 23(6):1013–1021
Herson PS, Traystman RJ (2014) Animal models of stroke: translational potential at present and in 2050. Future Neurol 9(5):541–551
Jickling GC, Sharp FR (2015) Improving the translation of animal ischemic stroke studies to humans. Metab Brain Dis 30(2):461–467
Jungreis CA, Nemoto E, Boada F, Horowitz MB (2003) Model of reversible cerebral ischemia in a monkey model. Am J Neuroradiol 24(9):1834–1836
Kemnitz JW (2011) Calorie restriction and aging in non-human primates. ILAR J 52(1):66–77
Kito G, Nishimura A, Susumu T, Nagata R, Kuge Y, Yokota C, Minematsu K (2001) Experimental thromboembolic stroke in cynomolgus monkey. J Neurosci Methods 105(1):45–53
Krieger DW, Yenari MA (2004) Therapeutic hypothermia for acute ischemic stroke: what do laboratory studies teach us? Stroke 35(6):1482–1489
Kuge Y, Yokota C, Tagaya M, Hasegawa Y, Nishimura A, Kito G, Tamaki N, Hashimoto N, Yamaguchi T, Minematsu K (2001) Serial changes in cerebral blood flow and flow—metabolism uncoupling in primates with acute thromboembolic stroke. J Cereb Blood Flow Metab 21(3):202–210
LaVerde GC, Jungreis CA, Nemoto E, Boada FE (2009) Sodium time course using 23Na MRI in reversible focal brain ischemia in the monkey. J Magn Reson Imaging 30(1):219–223
Molinari GF, Moseley JI, Laurent JP (1974) Segmented middle cerebral artery occlusion in primates: an experimental method requiring minimal surgery and anesthesia. Stroke 5(3):334–339
Muller PY, Brennan FR (2009) Safety assessment and dose selection for first-in-human clinical trials with immunomodulatory monoclonal antibodies. Clin Pharmacol Therapeut 85(3):247–258
O’Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59(3):467–477
Orset C, Macrez R, Young AR, Panthou D, Angles-Cano E, Maubert E, Agin V, Vivien D (2007) Mouse model of in situ thromboembolic stroke and reperfusion. Stroke 38(10):2771–2778
Qureshi AI, Suri MF, Ali Z, Ringer AJ, Boulos AS, Nakada MT, Alberico RA, Martin LB, Guterman LR, Hopkins LN (2005) Intraarterial reteplase and intravenous abciximab for treatment of acute ischemic stroke. Neuroradiology 47(11):845–854
Rodriguez-Mercado R, Ford GD, Xu Z, Kraiselburd EN, Martinez MI, Eterović VA, Colon E, Rodriguez IV, Portilla P, Ferchmin PA, Gierbolini L (2012) Acute neuronal injury and blood genomic profiles in a non-human primate model for ischemic stroke. Comp Med 62(5):427–438
Sato Y, Chin Y, Kato T, Tanaka Y, Tozuka Y, Mase M, Ageyama N, Ono F, Terao K, Yoshikawa Y, Hisatsune T (2009) White matter activated glial cells produce BDNF in a stroke model of monkeys. Neurosci Res 65(1):71–78
Sommer CJ (2017) Ischemic stroke: experimental models and reality. Acta Neuropathol 133(2):245–261
Susumu T, Yoshikawa T, Akiyoshi Y, Nagata R, Fujiwara M, Kito G (2006) Effects of intra-arterial urokinase on a non-human primate thromboembolic stroke model. J Pharmacol Sci 2006:0603240006
Tekam CKS, Tripathi AK, Kumar G, Patnaik R (2019) Emerging role of electromagnetic field therapy in stroke. In: Patnaik R, Tripathi A, Dwivedi A (eds) Advancement in the pathophysiology of cerebral stroke. Springer, Singapore
Tong FC, Zhang X, Kempf DJ, Yepes MS, Connor-Stroud FR, Zola S, Howell L (2015) An enhanced model of middle cerebral artery occlusion in non-human primates using an endovascular trapping technique. Am J Neuroradiol 36(12):2354–2359
Tripathi AK, Ali S, Mishra DP (2013) Attenuated antioxidant property of UV-B irradiated piperine in ischemia-reperfusion injury in SD rat. Environ Sci Technol 1:29–36
Tripathi AK, Dwivedi A, Pal MK et al (2014) Attenuated neuroprotective effect of riboflavin under UV-B irradiation via miR-203/c-Jun signaling pathway in vivo and in vitro. J Biomed Sci 21:39. https://doi.org/10.1186/1423-0127-21-39
Tripathi AK, Dhanesha N, Kumar S (2019a) Stroke induced blood-brain barrier disruption. In: Patnaik R, Tripathi AK, Dwivedi A (eds) Advancement in the pathophysiology of cerebral stroke. Springer, Singapore, pp 23–41
Tripathi AK, Tiwari SK, Mishra P, Jain M (2019b) Emerging role of microRNAs in cerebral stroke pathophysiology. In: Patnaik R, Tripathi A, Dwivedi A (eds) Advancement in the pathophysiology of cerebral stroke. Springer, Singapore
Truelsen T, Begg S, Mathers C (2000) The global burden of cerebrovascular disease. World Health Organisation, Geneva
Wu D, Yue F, Zou C, Chan P, Zhang YA (2012) Analysis of glucose metabolism in cynomolgus monkeys during aging. Biogerontology 13(2):147–155
Wu D, Chen J, Wang B, Zhang M, Shi J, Ma Y, Zhu Z, Yan F, He X, Li S, Dornbos IIID (2016) Endovascular ischemic stroke models of adult rhesus monkeys: a comparison of two endovascular methods. Sci Rep 6(1):1
Xie Y, Munekata K, Seo K, Hossmann KA (1988) Effect of autologous clot embolism on regional protein biosynthesis of monkey brain. Stroke 19(6):750–757
Zhang X, Tong F, Li CX, Yan Y, Kempf D, Nair G, Wang S, Muly EC, Zola S, Howell L (2015a) Temporal evolution of ischemic lesions in non-human primates: a diffusion and perfusion MRI study. PLoS One 10:2
Zhang L, Zhang RL, Jiang Q, Ding G, Chopp M, Zhang ZG (2015b) Focal embolic cerebral ischemia in the rat. Nat Protoc 10(4):539–547
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Jose, J.V. (2021). A Non-human Primate Model for Cerebral Stroke. In: Tripathi, A.K., Singh, A.K. (eds) Models and Techniques in Stroke Biology . Springer, Singapore. https://doi.org/10.1007/978-981-33-6679-4_4
Download citation
DOI: https://doi.org/10.1007/978-981-33-6679-4_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-6678-7
Online ISBN: 978-981-33-6679-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)